U.S. Food And Drug Administration Approves ABILIFY® (aripiprazole) For The Treatment Of Irritability Associated With Autistic Disorder In Patients
Links shared publicly online about this topic.
- 1,570total visits
U.S. Food And Drug Administration Approves ABILIFY® (aripiprazole) For The Treatment Of Irritability Associated With Autistic Disorder In Patients
View full resource at medicalnewstoday.com
Tags: Schizophrenia Medication, Antipsychotic Medication, Disease and Condition, Drug, Pharma, FDA, Abilify, Bristol-Myers Squibb
Most Recently Shared on November 28, 2009 at 10:11 pm By:
U.S. Food And Drug Administration Approves ABILIFY® (aripiprazole) For The Treatment Of Irritability Associated Wi... http://bit.ly/51H21G
Also Shared By:
FDA approves Stendra for erectile dysfunction
fda.gov — “The U.S. Food and Drug Administration today approved Stendra (avanafil), a new drug to treat erectile dysfunction.” View full resource at fda.gov
Most Recently Shared on April 27, 2012 at 6:59 pm By:
eyeonfda Pharma and Health Lawyer
#FDA issues press release about approval of Vivus ED drug Stendra - http://t.co/deRucBA2
Ironwood faces 3-month FDA delay for potential IBS drug linaclotide - Boston Business Journal
bizjournals.com — “Ironwood Pharmaceuticals Inc. (Nasdaq: IRWD) and its partner Forest Laboratories Inc. (NYSE: FRX) have announced the U.S. Food and Drug Administration will delay its approval decision for the companies’ potential drug for irritable bowel syndrome (IBS), called linaclotide.” View full resource at bizjournals.com
Most Recently Shared on April 24, 2012 at 7:18 pm By:
Inflammatory Bowel Syndrome OW Health
Ironwood faces 3-month FDA delay for potential IBS drug linaclotide: Ironwood Pharmaceuticals Inc. (Nasdaq: IRWD... http://t.co/l5H6RRmq
FDA approves i-Lipo fat-reduction device - - ModernMedicine
modernmedicine.com — “The Food and Drug Administration has cleared the i-Lipo (Chromogenex), a low-level laser diode fat-reduction device for body contouring, for U.S. marketing.” View full resource at modernmedicine.com
Most Recently Shared on April 23, 2012 at 5:45 am By:
CosmeticSurgeryTimes Medical Journal
FDA approves i-Lipo fat-reduction device http://t.co/hgpzSl8W #plasticsurgery
FDA says focused on tracking drugs after approval | Reuters
reuters.com — “ATLANTA (Reuters) - The U.S. Food and Drug Administration said on Saturday it now spends as much effort and resources on surveilling a drug after it is approved as it does in the pre-approval process.The” View full resource at reuters.com
Most Recently Shared on April 22, 2012 at 3:26 am By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
FDA says focused on tracking drugs after approval - Reuters http://t.co/S8Ty5Smt #medicine
FDA says focused on tracking drugs after approval | Reuters
reuters.com — “ATLANTA (Reuters) - The U.S. Food and Drug Administration said on Saturday it now spends as much effort and resources on surveilling a drug after it is approved as it does in the pre-approval process.The” View full resource at reuters.com
Most Recently Shared on April 22, 2012 at 12:20 am By:
Brad Lipson, DO Family Medicine Doctor, Physician, Active Health Library, and Doctor
FDA says focused on tracking drugs after approval: ATLANTA (Reuters) - The U.S. Food and Drug Administration sai... http://t.co/tyVaedT1
FDA says focused on tracking drugs after approval | Reuters
reuters.com — “ATLANTA (Reuters) - The U.S. Food and Drug Administration said on Saturday it now spends as much effort and resources on surveilling a drug after it is approved as it does in the pre-approval process.The” View full resource at reuters.com
Most Recently Shared on April 21, 2012 at 8:47 pm By:
FDA says focused on tracking drugs after approvalReutersBy Debra Sherman | ATLANTA (Reuters) - The US Food and D... http://t.co/JNtAA8e4
Report: FDA strengthens monitoring of post-approval drug safety
fda.gov — “A strengthened and modernized postmarket drug safety program has resulted in a substantial improvement in the U.S. Food and Drug Administration’s oversight of drugs once they reach the American public, according to a new report released today by the agency’s Center for Drug Evaluation and Research (CDER). The report, “Advances in FDA’s Safety Program for Marketed Drugs,” describes new scientific tools and enhanced capabilities that give the same priority to postmarket drug safety monitoring as t” View full resource at fda.gov
Most Recently Shared on April 21, 2012 at 8:42 pm By:
HealthTrendster Health Executive
Report: FDA strengthens monitoring of post-approval drug safety: A strengthened and… http://t.co/Nlax6RLR
FDA says focused on tracking drugs after approval | Reuters
reuters.com — “ATLANTA (Reuters) - The U.S. Food and Drug Administration said on Saturday it now spends as much effort and resources on surveilling a drug after it is approved as it does in the pre-approval process.The” View full resource at reuters.com
Most Recently Shared on April 21, 2012 at 8:30 pm By:
Brad Lipson, DO Family Medicine Doctor, Physician, Active Health Library, and Doctor
FDA says focused on tracking drugs after approval: ATLANTA (Reuters) - The U.S. Food and Drug Administration sai... http://t.co/a47c8atr
Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients
news-medical.net — “Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.” View full resource at news-medical.net
Most Recently Shared on April 18, 2012 at 4:01 pm By:
Diabetes News: Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients:... http://t.co/ol32Ok8K
BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval | BioPortfolio.com
bioportfolio.com — “From BioPortfolio: Allergan, Inc. (NYSE: AGN) announced today that April 15, 2012 will mark the 10-year anniversary of the U.S. Food and Drug Administrationâ??s (FDA) approv...” View full resource at bioportfolio.com
Most Recently Shared on April 13, 2012 at 1:46 pm By:
BioPF Dermatology Dermatology and Health News Feed
BioPortfolio News BOTOXÂ Cosmetic onabotulinumtoxinA Celebrates 10Year Anniversary of U.S. Foo... http://t.co/ogZ38usV BioPortfolio News
Affymax and Takeda Announce FDA Approval of OMONTYS® (Peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Adult Patients on Dialysis - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Affymax, Inc. and Takeda Pharmaceutical Company Limited , today announced that the U.S. Food and Drug Administration approved OMONTYS® Injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis.” View full resource at finance.yahoo.com
Most Recently Shared on March 27, 2012 at 6:44 pm By:
Luke Timmerman Health Communicator
Affymax conf call coming up fast, 2:45 pm ET/11:45 am PT. http://t.co/8TpSAOyY
Boniva generics receive FDA approval for treatment, prevention of osteoporosis
news-medical.net — “The U.S. Food and Drug Administration today approved the first generic versions of Boniva (ibandronate) tablets, a once-monthly product to treat or prevent osteoporosis in women after menopause.” View full resource at news-medical.net
Most Recently Shared on March 27, 2012 at 1:12 pm By:
Boniva generics receive FDA approval for treatment, prevention of osteoporosis: The U.S. Food and Drug Administr... http://t.co/YbYOsv15
Surfaxin receives FDA approval for prevention of RDS in premature infants
news-medical.net — “The U.S. Food and Drug Administration today approved Surfaxin (lucinactant) for the prevention of respiratory distress syndrome (RDS), a breathing disorder that affects premature infants.” View full resource at news-medical.net
Most Recently Shared on March 27, 2012 at 1:12 pm By:
Surfaxin receives FDA approval for prevention of RDS in premature infants: The U.S. Food and Drug Administration... http://t.co/gUtgTOgn
FDA approves Teva's QNASL nasal aerosol corticosteroid
news-medical.net — “Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has approved QNASL Nasal Aerosol, a new, "dry" nasal aerosol corticosteroid that treats seasonal nasal and year-round nasal allergy symptoms in adults and adolescents 12 years of age and older.” View full resource at news-medical.net
Most Recently Shared on March 26, 2012 at 7:03 pm By:
Asthma News: FDA approves Teva's QNASL nasal aerosol corticosteroid: Teva Pharmaceutical Industries Ltd. announc... http://t.co/2cZSMyF6
FDA To Address Antibiotic Overuse In Livestock, Protect Public Health
huffingtonpost.com — “The U.S. Food and Drug Administration must act on scientific knowledge that the overuse of antibiotics in food animals has contributed to the rise of antibiotic-resistant infections in humans. This ruling made by a federal court on Thursday night now compels the FDA to withdraw approvals for most non-therapeutic uses of penicillin and tetracyclines in livestock, unless drugmakers are able to show that they are safe.” View full resource at huffingtonpost.com
Most Recently Shared on March 24, 2012 at 7:12 am By:
Marion Ross PhD Psychologist, PhD, Doctor, and CAM
RT @timesuredoesfly: FDA To Address Antibiotic Overuse In Livestock, Protect Public Health http://t.co/E38fkUzd -i loved reading this.
Advertisement
MNT Autism News
@mnt_autism
U.S. Food And Drug Administration Approves ABILIFY® (aripiprazole) For The Treatment Of Irritability Associated.. http://bit.ly/51H21G
1 year ago...